PRPH May 2024 2.500 call
| Previous close | 3.7000 |
| Open | 3.7000 |
| Bid | 1.4500 |
| Ask | 2.8500 |
| Strike | 2.50 |
| Expiry date | 2024-05-17 |
| Day's range | 3.7000 - 3.7000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Insider MonkeyProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2024 Earnings Call Transcript
ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2024 Earnings Call Transcript May 9, 2024 ProPhase Labs, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Noella Alexander-Young: Welcome to today’s presentation. My name is Noella Alexander-Young, Virtual Event Moderator here at Renmark Financial […]
GlobeNewswireProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated
Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database and patented discoveries in its BE-Smart Esophageal Cancer Diagnostic Test. BE-Smart Cancer Test continues to advance towards second half commercialization. Company is issuing this updated Press Release solely to correct typographical errors in Weighted average common shares outstanding and Earnings (L
- GlobeNewswire
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.
Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database and patented discoveries in its BE-Smart Esophageal Cancer Diagnostic Test. BE-Smart Cancer Test continues to advance towards second half commercialization. Company to hold a conference call Thursday, May 9, 2024, at 11:00 AM ET Garden City, NY, May 09, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NAS
